{"DataElement":{"publicId":"5580453","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Involvement Final Score","preferredDefinition":"Final score that represents the percentage of body surface area involved by disease signs and the cutaneous features scale associated with cGVHD (chronic Graft vs. Host Disease).","longName":"CGVHD_SKN_FNL_SCR","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5040553","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin Involvement","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages._To have a connection by participation or association or use; sharing in an activity or process.","longName":"5040551v1.0:2192548v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5040551","version":"1","preferredName":"Chronic Graft Versus Host Disease Skin","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.:An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","longName":"C4981:C12470","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-468B-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-4699-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"COOPERM","dateModified":"2016-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5579010","version":"1","preferredName":"Chronic Graft Versus Host Disease Final Skin NIH Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"FINAL_SKIN_SCR","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score 3","valueDescription":"Score 3","ValueMeaning":{"publicId":"5589096","version":"1","preferredName":"Score 3","longName":"5589096","preferredDefinition":"Body surface area involvement is greater than 50 percent and there are any skin features that are Score 3. This score is also used when superficial sclerotic features are present (Score 2), but there is impaired mobility or ulceration (Score 3).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Skin Score 3","conceptCode":"C131029","definition":"Body surface area involvement is greater than 50 percent and there are any skin features that are Score 3. This score is also used when superficial sclerotic features are present (Score 2), but there is impaired mobility or ulceration (Score 3).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42B53099-7953-042D-E053-F662850AC8BA","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42B52859-8151-6258-E053-F662850A6D18","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"ONEDATA","dateModified":"2016-12-02","deletedIndicator":"No"},{"value":"Score 2","valueDescription":"Score 2","ValueMeaning":{"publicId":"5589097","version":"1","preferredName":"Score 2","longName":"5589097","preferredDefinition":"Body surface area involvement is 19-50 percent and there are superficial sclerotic features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Skin Score 2","conceptCode":"C131028","definition":"Body surface area involvement is 19-50 percent and there are superficial sclerotic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42B53099-7976-042D-E053-F662850AC8BA","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42B52859-8165-6258-E053-F662850A6D18","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"ONEDATA","dateModified":"2016-12-02","deletedIndicator":"No"},{"value":"Score 1","valueDescription":"Score 1","ValueMeaning":{"publicId":"5589098","version":"1","preferredName":"Score 1","longName":"5589098","preferredDefinition":"Body surface area involvement is 1-18 percent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Skin Score 1","conceptCode":"C131027","definition":"Body surface area involvement is 1-18 percent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42B53099-7999-042D-E053-F662850AC8BA","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42B52859-8179-6258-E053-F662850A6D18","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"ONEDATA","dateModified":"2016-12-02","deletedIndicator":"No"},{"value":"Score 0","valueDescription":"Score 0","ValueMeaning":{"publicId":"5589099","version":"1","preferredName":"Score 0","longName":"5589099","preferredDefinition":"Body surface area involvement is 0 percent and there are no sclerotic features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GvHD Final Skin Score 0","conceptCode":"C131026","definition":"Body surface area involvement is 0 percent and there are no sclerotic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42B53099-79BC-042D-E053-F662850AC8BA","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42B52859-818D-6258-E053-F662850A6D18","beginDate":"2016-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-02","modifiedBy":"ONEDATA","dateModified":"2016-12-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2193207","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFA-EFD4-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4196D0FE-E71D-3FA8-E053-F662850A38EE","latestVersionIndicator":"Yes","beginDate":"2016-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-18","modifiedBy":"COOPERM","dateModified":"2016-12-21","changeDescription":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Final GVHD Skin Score","type":"Preferred Question Text","description":"Final GVHD Skin Score","url":null,"context":"CCR"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Skin (scored by BSA):","url":null,"context":"COG"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41C23ECD-7080-3FE3-E053-F662850AB9B3","latestVersionIndicator":"Yes","beginDate":"2016-11-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-20","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeDescription":"Created for NIH Score CRF as requested by Y. Yakovlev. mc 11/18/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}